Date of Appointment:
25 November 2021
Noor Azri Bin Dato’ Sri Noor Azerai graduated with a Bachelor’s Degree (Hons.) in Finance, Investment and Risk from the London Institute of Banking and Finance, United Kingdom in 2021.
In 2018, Noor Azri had gained his experiences in the Corporate Finance and Investment in Equity & Commodity Derivatives in M&A Securities Sdn Bhd and Maybank Investment Bank Berhad. His key success involves the Initial Public Offering exercises and managing portfolios of high value net worth individuals.
Currently, he is an Executive Director of Malaysian Genomics Resource Centre Berhad and holding few positions in Sarawak Consolidated Industries Berhad as well as Caely Holdings Berhad. He is also in the Board of several subsidiary companies, Bintai Group and other private limited companies in Malaysia and United Kingdom. Noor Azri holds a directorship in public listed companies of Bintai Kinden Corporation Berhad and NWP Holdings Berhad.